Current Directions in Radiopharmaceutical Research and Development (Developments in Nuclear Medicine) (Reprint)

個数:

Current Directions in Radiopharmaceutical Research and Development (Developments in Nuclear Medicine) (Reprint)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 260 p.
  • 言語 ENG
  • 商品コード 9789401072892
  • DDC分類 616

Full Description

Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research.

Contents

1. Radiopharmaceutically relevant chemistry of technetium and rhenium..- 2. Bifunctional chelators for Tc-99m.- 3. Medium half-life inorganic radionuclides for PET imaging.- 4. Therapeutic radionuclides: making the right choice..- 5. Radiopharmaceuticals for imaging hypoxia.- 6. Genetic engineering of monoclonal antibodies.- 7. The development of radiopharmaceuticals for imaging CNS receptors.- 8. Imaging the functions of the cell nucleus..- 9. Steroid hormone receptors as targets for diagnostic imaging.- 10. Radiolabelling oligonucleotides with imagable radionuclides.- 11. Radioligand binding assays: theory and practice.- 12. Molecular modelling: an introduction.- 13. Computer modelling of metal-based radiopharmaceuticals.- 14. Microautoradiography.

最近チェックした商品